Ann: Investor Presentation, page-5

Companies themselves determine whether announcements are ‘market sensitive’, and according to the ASX’s Continuous Disclosure rules, ‘market-sensitive information’ is information that the company believes ‘a reasonable person would expect to have a material effect on the price or value of the entity’s securities’.

Personally it is negative if one looks at the commentary around sales, certainly nothing in there to drive the price upwards, a $15 looks more likely, happy to be wrong but that is just my take:
Current observations
• Unwind of 3Q20 pantry stocking in the early part of FY21
• Softness in retail daigou continuing due to reduced tourism from China and international student numbers
• Some disruption being seen in the corporate daigou / reseller channel resulting from Stage 4 lockdown in Victoria
and
FY21
• Globally, there continues to be uncertainty resulting from COVID-19, and the potential for moderation of economic activity. This could impact
consumer behaviour in our core markets, as well as participants within the supply chain, most notably in China
• Notwithstanding these uncertainties, overall for FY21, we anticipate continued strong revenue growth supported by our continued investment in
marketing and organisational capability
• FY21 EBITDA margin is expected to be in the order of 30% to 31% reflecting
‒ Higher raw and packaging material costs partially offset by price increases
‒ Increase of marketing investment
‒ FX benefit of prior year not expected to be replicated
‒ 3Q20 COVID-19 benefit not replicated
• FY21 Capex is currently expected to be $50 million due to our ERP investment and capital projects supporting fresh milk processing in Australia